Ainos Q3 2025 results omit financials; focuses on AI Nose partnerships and patents

Ainos, Inc.

2025-Q3 EPS reported -$2.61 revenue$113,037

No net revenue or EPS disclosed in Q3 2025 press release; SG&A down 22% YoY, total opex down 8%.
Strategic partnerships with NEXCOM (industrial edge AI) and Topco Scientific (semiconductor distribution) announced.
Received 7 new patents in Europe, Germany, Taiwan, China; now holds 123 active patents.
Launched first commercial portable AI Nose module for industrial and healthcare use in August 2025.
At annual meeting, all 7 director nominees elected; auditor YCM CPA INC. ratified; 950K share award approved.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.